Adaptive Biotechnologies (ADPT) Capital Expenditures (QoQ) (2018 - 2026)
Adaptive Biotechnologies (ADPT) Capital Expenditures (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.26% |
| Dec 31, 2025 | 415.99% |
| Sep 30, 2025 | 3,315.38% |
| Jun 30, 2025 | -93.84% |
| Mar 31, 2025 | 163.75% |
| Dec 31, 2024 | -76.74% |
| Sep 30, 2024 | -83.81% |
| Jun 30, 2024 | 90.58% |
| Mar 31, 2024 | 279.55% |
| Dec 31, 2023 | 88.31% |
| Sep 30, 2023 | -206.90% |
| Jun 30, 2023 | 201.03% |
| Mar 31, 2023 | 283.44% |
| Dec 31, 2022 | -34.93% |
| Sep 30, 2022 | -419.14% |
| Jun 30, 2022 | -93.21% |
| Mar 31, 2022 | 141.30% |
| Dec 31, 2021 | 74.95% |
| Sep 30, 2021 | -234.97% |
| Jun 30, 2021 | 39.14% |